Commentary on "HER2/neu as a predictive factor in breast cancer" Journal Article
| Authors: | Van Poznak, C.; Seidman, A. D. |
| Article Title: | Commentary on "HER2/neu as a predictive factor in breast cancer" |
| Keywords: | immunohistochemistry; controlled study; unclassified drug; clinical trial; note; paclitaxel; antineoplastic agent; prospective study; gene overexpression; controlled clinical trial; breast cancer; gene amplification; randomized controlled trial; prediction; monoclonal antibody; fluorescence in situ hybridization; tamoxifen; taxane derivative; trastuzumab; anthracycline; dna topoisomerase (atp hydrolysing); drug sensitivity; antiestrogen; oncogene neu; genetic transcription and translation; polyclonal antibody; prognosis; human; monoclonal antibody 4d5 |
| Journal Title: | Clinical Breast Cancer |
| Volume: | 2 |
| Issue: | 2 |
| ISSN: | 1526-8209 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2001-07-01 |
| Start Page: | 136 |
| End Page: | 137 |
| Language: | English |
| PROVIDER: | scopus |
| DOI: | 10.1016/S1526-8209(11)70307-X |
| DOI/URL: | |
| Notes: | Export Date: 21 May 2015 -- Source: Scopus |
